Randomized Comparison of Direct Thrombin Inhibition Versus Heparin in Conjunction With Fibrinolytic Therapy for Acute Myocardial Infarction: Results From the GUSTO-IIb Trial-Reference-Cited by-同舟云学术

Randomized Comparison of Direct Thrombin Inhibition Versus Heparin in Conjunction With Fibrinolytic Therapy for Acute Myocardial Infarction: Results From the GUSTO-IIb Trial

Published:1998-06 Issue:7 Volume:31 Page:1493-1498
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Metz Brian K,White Harvey D,Granger Christopher B,Simes R.John,Armstrong Paul W,Hirsh Jack,Fuster Valentin,MacAulay Cynthia M,Califf Robert M,Topol Eric J

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction;Becker;J Am Coll Cardiol,1996

2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction;N Engl J Med,1993

3. Clot-bound thrombin is protected from inhibition by heparin-antithrombin but is susceptible to inactivation by antithrombin III-independent inhibitors;Weitz;J Clin Invest,1990

4. Initial experience with hirudin and streptokinase in acute myocardial infarction;Lee;Am J Cardiol,1995

5. Effects of recombinant hirudin on early and late coronary patency in acute myocardial infarction patients treated with streptokinase (the HIT-SK study);Molhoek;Circulation,1995

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The quest for effective pharmacological suppression of neointimal hyperplasia;Current Problems in Surgery;2020-08

2. Controversies in the Management of ST Elevation Myocardial Infarction;Interventional Cardiology Clinics;2016-10

3. Computational design, functional analysis and antigenic epitope estimation of a novel hybrid of 12 peptides of hirudin and reteplase;Journal of Molecular Modeling;2015-08-13

4. Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review;ISRN Cardiology;2014-02-06

5. ENZYMES;Biotechnology and Biopharmaceuticals;2013-10-25